SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2009-01-12
Filing Date Changed: 2009-01-16
Documents: 2
SEC Accession No.
0000812796-09-000002
Filing date: 2009-01-16
Accepted: 2009-01-16 15:01:36
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K dor8kchangeauditors.htm 29725 CHANGE IN AUDITORS
2 EX-16.1 sweeneysecletter.htm 6424 LETTER TO SEC TO EFFECT CHANGE
0000812796-09-000002.txt 37873 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09531198
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200
 Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628